Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
This study was designed to investigate and compare demographic and clinical features with specific emphasis on age at onset, age at first treatment and, in particular, on duration of untreated illness (DUI), in patients with different mood and anxiety disorders. Study sample included 729 outpatients with the following diagnoses: major depressive disorder (n=181), bipolar disorder type I (BD I, n=115) and II (BD II, n=186), generalized anxiety disorder (n=100), panic disorder (n=96), and obsessive-compulsive disorder (n=51). Main demographic and clinical variables of the sample were compared among the diagnostic groups using one-way analysis of variance or chi tests. The diagnostic groups showed significant differences in relation to age at onset and age at first pharmacological treatment and in relation to latency to treatment. In particular, patients with major depressive disorder showed the shortest DUI (39.08 months), whereas patient with BD II showed the longest DUI (97.2 months) in comparison with the other groups. Within the group with anxiety disorders (F=7.512, P<0.001), patients with panic disorder showed the shortest DUI (44.35 months), whereas patients with obsessive-compulsive disorder showed the longest DUI (90.57 months). The present findings suggest that patients with different mood and anxiety disorders show significant differences in terms of age at onset, age at first treatment and, consequently, DUI, which potentially reflect different reasons influencing treatment delay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, P. S., Berglund, P., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.603 · Cited by 1,325
Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431 · cited 1×
“…(i.e. antidepressants for MDD and anxiety disorders or mood stabilizers for BD) at adequate dosage and for a proper period of time according to currently available guidelines (Grunze et al., 2002; Kocsis, 2006; Dennehy et al., 2007; Bandelow et al., 2008; Lam et al., 2009; Yatham et al., 2009).”
MethodDelays in Initial Treatment Contact after First Onset of a Mental Disorder
Wang, P. S., Berglund, P. A., Olfson, M., & Kessler, R. C. (2004) · Health Services Research · doi:10.1111/j.1475-6773.2004.00234.x · Cited by 249 · cited 1×
“In addition, patients with PD may look for psychiatric services sooner than patients with other anxiety disorders for the acute and disabling symptoms characteristic of panic attacks (Wang et al., 2004).”
BackgroundGrunze, H., Kasper, S., Goodwin, G., Bowden, C., Baldwin, D., Licht, R., Vieta, E., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150612 · Cited by 185 · cited 2×
“…(i.e. antidepressants for MDD and anxiety disorders or mood stabilizers for BD) at adequate dosage and for a proper period of time according to currently available guidelines (Grunze et al., 2002; Kocsis, 2006; Dennehy et al., 2007; Bandelow et al., 2008; Lam et al., 2009; Yatham et al., 2009).”
MethodCan We Predict the Persistence of Depression?
Scott, J., Eccleston, D., & Boys, R. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.161.5.633 · Cited by 131 · cited 1×
“Even though literature about the role of the DUI in mood and anxiety disorders is less robust, clinical studies have reported a negative role for a longer DUI in these conditions as well (Scott et al., 1992; Kessler et al., 1998; Gormley et al., 1999).”
BackgroundService utilisation for anxiety in an Australian community sample
Issakidis, C., & Andrews, G. (2002) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270200009 · Cited by 118
Benzodiazepines and anxiety disorders: a review for the practicing physician
Kaplan, E. M., & DuPont, R. L. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x48401 · Cited by 55
Cited by
Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment
Hirschtritt, M. E., Bloch, M. H., & Mathews, C. A. (2017) · JAMA · doi:10.1001/jama.2017.2200 · Cited by 493
Altamura, A. C., Buoli, M., Caldiroli, A., Caron, L., Cumerlato Melter, C., Dobrea, C., Cigliobianco, M., & Zanelli Quarantini, F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.024 · Cited by 162
Self-citationEarly intervention for obsessive compulsive disorder: An expert consensus statement
Fineberg, N. A., Dell'Osso, B., Albert, U., Maina, G., Geller, D., Carmi, L., Sireau, N., Walitza, S., Grassi, G., Pallanti, S., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.02.002 · Cited by 158
“, 2016a), and the duration of untreated illness (DUI) for OCD remains one of the highest for any severe mental disorder (Altamura et al., 2010).”
BackgroundInfluentialSelf-citationDuration of untreated illness as a key to early intervention in schizophrenia: a review.
Murru, A., & Carpiniello, B. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.003 · Cited by 135
“From an epidemiologic perspective, large sample studies in SCZ found mean values of DUP ranging from 8 to 48 weeks, whereas higher DUI values, comprised between 3 and 8 years, on average, were reported for mood disorders and anxiety disorders [9], [13]–[17] Although the applicability of DUI may vary according to diffe…”
BackgroundDell’Osso, B., Glick, I. D., Baldwin, D. S., & Altamura, A. C. (2013) · Psychopathology · doi:10.1159/000338608 · Cited by 118
Self-citation
Metadata
- Authors
- Altamura, A. C., Buoli, M., Albano, A., & DellʼOsso, B.
- Venue
- International Clinical Psychopharmacology
- Published
- 2010-05
- Volume
- 25
- Issue
- 3
- Pages
- 172-179
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2046268211
- Cited by
- 134
- References
- 7
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study. https://app.cochat.ai/papers/10.1097/yic.0b013e3283384c74
- The paper
- Altamura, A. C., Buoli, M., Albano, A., & DellʼOsso, B. (2010). Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0b013e3283384c74
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.